Abstract
About 20-25% of patients have diagnosable liver metastases at the time of colorectal cancer diagnosis determination. Hepatic resection R0, i. e. removal of the malignant locus up to healthy liver tissue, is currently the only curative treatment method which, in combination with perioperative chemotherapy, enables the survival of up to 60 % of these patients.
Removal of the primary tumor is conditional for liver resection efficacy. Currently a consensus, from which a definite, based on a sufficient number of quality clinical trials, standard procedure for the diagnosis and treatment of these patients would result, is missing.